Physician profile
William S Epstein
NPI 1740285667
$2,094.66
in general payments reported to CMS, 2019-2025
18 companies · $333 in 2025
The $333 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,105 · 2020: $106 · 2021: $28.89 · 2022: $94.32 · 2023: $249 · 2024: $179 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $737 · Entertainment: $23.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $736.57 |
| Entertainment | $23.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $554.39 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $272.56 | 2019-2025 | Cequa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $268.95 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $165.42 | 2023-2025 | Miebo, Xiidra |
| Glaukos Corporation | $146.21 | 2025 | Istent Infinite, Idosetr |
| Thea Pharma INC. | $135.56 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $122.94 | 2019 | |
| Astellas Pharma US INC | $107.71 | 2024 | Izervay |
| Johnson & Johnson Surgical Vision, INC. | $77.94 | 2019 | |
| Horizon Therapeutics Plc | $69.70 | 2021-2023 | Tepezza |
| Aerie Pharmaceuticals, INC. | $44.49 | 2019-2020 | |
| Optos, INC. | $23.78 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Amgen INC. | $23.71 | 2025 | Tepezza |
| Novartis Pharmaceuticals Corporation | $22.82 | 2022 | |
| Alimera Sciences, INC. | $18.00 | 2024 | Iluvien, Yutiq |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tearlab Corp | $14.11 | 2021 | |
| Allergan, INC. | $13.52 | 2022 | |
| Abbvie INC. | $12.85 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Epstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.